The physIQ accelerateTM solution monitors patients 24/7 to expedite decentralized clinical trials, evaluate drug safety, validate therapeutic efficacy and ease the path to swifter regulatory submissions with real-world patient data.  We do this by offering a robust digital platform with the perfect trifecta of:

1.      Sensors: 100% device agnostic, right biosensor for right patient, experts in signal detection, multivariate data collection, near real-time continuous RPM

2.      Analytics: 5 FDA-cleared biomarkers, AI-based insights, 40 algorithms, 30-year machine learning experience, “we learn you and detect when you’re changing”

3.      Infrastructure: medical grade, highly scalable, 2M+ hours of on-body patient data, consistent and clean data “you can use,” keeps original source data, rich data lake/trove

As a leading pioneer of patient data insights, physIQ enables clinicians and researchers to make smarter, faster, better decisions to drive healthier outcomes. PhysIQ is the only company with a medical grade, AI-powered digital platform that “learns” and continuously monitors each person’s health status against their own unique baseline to provide proactive, predictive and personalized insights from any wearable biosensor.  Near real-time physiological data, combined with advanced analytics, helps healthcare delivery and life sciences organizations to detect potentially life-threatening events sooner, deliver preventive care and bring new treatments to market faster.  

Myia is a data driven operating system for virtual care. Myia equips Patients and Clinicians with the tools needed for the patients transition from hospital at home, to 30 day readmit avoidance, to traditional RPM. The shift to value-based reimbursement models necessitates more preventative models of care, Myia's platform crosses these models and facilitates cost savings. Myia is partnering with the leading healthcare organizations around the country. Partners like Mercy Virtual, one of the country's leaders in continuous and preventative chronic care management, including patients with Heart Failure, COPD, Diabetes, and Hypertension. Myia improves quality of life for patients and predicts and prevents costly medical events for care providers. Myia takes a device agnostic approach to daily patient monitoring, applies proprietary machine learning for smart triage, and has a clinician centric application to surface the right patient at the right time into workflow. Partnerships with BioIntellisense and Dispatch health bring a complete Hospital at Home offering to the market.

PhysIQ products are built on decades of machine learning experience combined with leading medical insights to create full featured remote patient monitoring solution.

The AccelerateIQ solution is built on 5 FDA-cleared biomarkers, AI-based insights, 40 algorithms, 30-year machine learning experience. No other remote patient monitoring solution can match this experience.

There are no homegrown options that do all that Myia is capable of from a Clinical Perspective. Myia can be used to monitor patient data in four major settings, Inpatient, Hospital at Home, 30 Day readmit avoidance programs, long term RPM programs.

Myia is the only RPM vendor that we are aware of with Data Scientist on staff as well as Data Analyst who work to stratify data and work with Clients to maximize the value of the Myia platform. By looking across patients clinical indication Myia can predict who should be on the program as well as whom is likely to require a hospital visit. These analytics help reduce costs and patient outcomes.